logo

Ziopharm Oncology Inc. (ZIOP)



Trade ZIOP now with
  Date
  Headline
7/8/2020 8:35:38 AM Ziopharm Oncology Doses First DIPG Patient In Phase 1/2 Trial Of Controlled IL-12
2/5/2020 9:09:44 AM Ziopharm Oncology Prices Underwritten Public Offering Of 27.83 Mln Shares At $3.25/shr
10/1/2019 8:23:01 AM Ziopharm Oncology Announces FDA Clearance Of IND For Rapid Personalized Manufacture Of CD19-specific CAR-T
8/23/2019 7:05:35 AM Ziopharm Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
7/24/2019 8:39:23 AM Ziopharm Oncology Names Sath Shukla As CFO
6/11/2019 8:19:15 AM Ziopharm Oncology Announces FDA Clearance Of IND For Sleeping Beauty TCR-T Cell Therapy Trial At NCI
6/2/2019 9:21:26 AM Ziopharm Oncology Provides Positive Clinical Data For Controlled IL-12 For Recurrent Glioblastoma At ASCO Annual Meeting
12/19/2018 7:13:58 AM Ziopharm Oncology And TriArm Form JV To Develop And Commercialize Sleeping Beauty CAR T In China, Taiwan And Korea
12/13/2018 4:27:22 PM Ziopharm Oncology Promotes David Mauney To President
11/12/2018 7:11:21 AM Ziopharm Announces Immuno-oncology Deal With Regeneron To Evaluate Combination Therapy For Patients With Brain Cancer
11/12/2018 6:59:47 AM Ziopharm Oncology Announces $50 Mln Private Placement
10/9/2018 7:05:29 AM Ziopharm Oncology, Precigen Announce New Definitive License Agreement
6/18/2018 7:35:33 AM Ziopharm Oncology: FDA Placed On Clinical Hold Of ING Application For Phase 1 Trial For CD19-targeted CAR T Therapy
6/4/2018 7:59:32 AM Ziopharm Presents Data Showing Anti-tumor Immune Response Of Controlled IL-12 Platform In Breast Cancer And Glioblastoma